Cosmos Limited is a Kenya-based company founded in 1978, with a focus on manufacturing quality generic medicines at an affordable price for Kenyans. The company has over 200 registered products and aims to make non-communicable diseases and diseases requiring regular medication a priority. With a dedicated focus on Research and Development, Cosmos is spearheading a movement to increase the quality of life, convenience, and compliance of the people. The company is a 3rd generation family business of technocrats with a passionate presence in 10 Sub Saharan African countries and employs over 400 people. Their latest goal is to gain international standard recognition through WHO prequalification for most of their products. Cosmos' dedication to improving access to quality medicines makes it a compelling opportunity for potential investors seeking to impact the healthcare industry in Africa.
There is no investment information
No recent news or press coverage available for Cosmos Limited.